Source:PIB
Subject: Health, Governance and Regulatory Framework (Drug Regulation, Pharmaceutical Supply Chain)|Target exams: UPSC
Key points for Prelims: Drugs Rules, 1945, Good Storage and Distribution Practices (GSDP), CDSCO, Ministry of Health and Family Welfare
Mains syllabus mapping
- General Studies Paper 2: Health sector: regulation of pharmaceuticals, role of regulatory bodies such as CDSCO, Centre-State coordination in drug control
- General Studies Paper 3: Quality control and regulation in the pharmaceutical supply chain, prevention of counterfeit and spurious drugs
Drugs and Cosmetics Rules, 1945 (proposed incorporation of Good Storage and Distribution Practices): quick facts
- Scope of GSDP
- Procurement, purchasing, storage, distribution, transportation, documentation and record-keeping
- Enforcement bodies
- Central and State drug-control authorities for inspection and enforcement
- Current status
- Draft proposal; stakeholders invited to send objections and suggestions to the Under Secretary (Drugs Regulation), Ministry of Health and Family Welfare, by post or email
Key facts for one-day exams
- GSDP stands for Good Storage and Distribution Practices.
- The proposal concerns the Drugs Rules, 1945.
- CDSCO developed the underlying GSDP guidance.
- The Ministry of Health and Family Welfare proposed incorporating the guidelines.
- The proposed guidelines cover pharmaceutical storage and transportation.
Good Storage and Distribution Practices: why in the news?
The Ministry of Health and Family Welfare has proposed incorporating Good Storage and Distribution Practices into the Drugs Rules, 1945, a move that would make the guidelines legally binding and strengthen regulatory oversight of the pharmaceutical supply chain from manufacturer to patient.
The Union Ministry of Health and Family Welfare has proposed incorporating Good Storage and Distribution Practices (GSDP) guidelines for pharmaceutical products into the Drugs Rules, 1945. The proposal, which builds on guidance developed by the Central Drugs Standard Control Organisation (CDSCO), is intended to ensure that the quality, safety, efficacy and integrity of pharmaceutical products are maintained throughout the distribution chain, from the manufacturer or importer to the point of supply to the patient.
The proposed framework covers procurement, purchasing, storage, distribution, transportation, documentation and record-keeping. According to the ministry, maintaining appropriate storage and distribution conditions is essential to preserving the quality and integrity of pharmaceutical products beyond the manufacturing stage. The guidelines seek to address potential risks such as deterioration, contamination, mix-ups, falsification, diversion and unauthorised distribution. The incorporation of GSDP requirements into the Drugs Rules is expected to strengthen regulatory oversight, inspection and enforcement by Central and State drug-control authorities, and to enhance accountability among manufacturers, importers, wholesalers, distributors, stockists and other entities involved in the distribution process.
The ministry has invited stakeholders and members of the public to submit objections and suggestions to the Under Secretary (Drugs Regulation), Ministry of Health and Family Welfare, either by post or via email.
Key features and how it works
- The Rules classify drugs into schedules (for example Schedule H, H1 and X) and set rules for storage, sale, display and prescription of each schedule.
- GSDP requirements would cover procurement, purchasing, storage, distribution, transportation, documentation and record-keeping across the supply chain.PIB
- Incorporating GSDP into the Rules would make the guidelines legally binding and give Central and State drug-control authorities a basis for inspection and enforcement.
- The framework seeks to improve documentation, record-keeping and traceability, and to make manufacturers, importers, wholesalers, distributors and stockists accountable.PIB
Related Static GK and comparison
- CDSCO is responsible for drug approvals, clinical trials, drug standards, imported drug quality control and coordination of State Drug Control Organisations.cdsco.gov.in
- Drugs Controller General of India (DCGI): head of the CDSCO, responsible for approval of licences for specified drug categories such as blood and blood products, IV fluids, vaccines and sera, and for setting standards for manufacturing, sale, import and distribution of drugs.
- Drugs and Cosmetics Act, 1940: the parent law that regulates import, manufacture and distribution of drugs in India; originally called the Drug Act and passed in 1940 on the recommendations of the Chopra Committee; the Rules of 1945 were made under it.
- Schedule H1 (notified in 2013): covers third and fourth generation antibiotics, some psychotropic drugs and anti-TB drugs; a separate register must be kept for their supply.
- Schedule X lists addictive drugs such as narcotics and psychotropics that have medicinal uses and must be kept under lock and key. Schedule H regulations also apply.
Achievements
- The proposal would incorporate GSDP guidelines into the Drugs Rules, 1945, building on CDSCO guidance.PIB
- Clear coverage of the full supply chain, from manufacturer or importer to the patient, makes responsibility easier to assign at each stage.
- The proposed framework would promote documentation, record-keeping and traceability.PIB
Challenges
- Enforcement depends on State drug-control authorities, so uneven capacity across States may affect uniform implementation.
- India's drug-regulatory framework has been criticised for lax laws, exploitable loopholes and inadequate enforcement.
- Smaller wholesalers and stockists may find new documentation and storage requirements costly to meet.
Way forward
- Monitor outcomes through regular inspection data from Central and State drug-control authorities.
- Provide handholding and guidance to small distributors and stockists to meet the new storage and record-keeping norms.
- Converge GSDP enforcement with the existing schedule-based controls and the CDSCO's inspection network.
Connected to this news
Drugs and Cosmetics Rules, 1945 (proposed incorporation of Good Storage and Distribution Practices)
The Drugs and Cosmetics Rules, 1945 are the implementing rules of the Drugs and Cosmetics Act, 1940, and the Centre has proposed adding Good Storage and Distribution Practices (GSDP) to them so that supply-chain storage and distribution norms become legally binding.
Timeline
19 November 2026This story
Health Ministry proposed incorporating GSDP guidelines (covering storage, distribution and record-keeping of drugs) into the Drugs Rules, 1945, making them legally binding; stakeholders invited to send objections and suggestions.
19 November 2026
Draft notification G.S.R. 987(E) proposes separate licensing for bulk drug wholesale under the Drugs Rules, 1945, using new Forms 19-BC and 20-BC, with existing licensees given time to comply.
Read the story19 November 2026
Health Ministry published a draft amendment to the Drugs Rules, 1945, proposing continued Schedule M exemptions for medicinal gases, empty gelatin capsules and disinfectant fluids, based on a DTAB recommendation, open for public objections.
Read the story8 September 2026
Draft notification G.S.R. 791(E) proposed mandatory CCTV at retail premises selling Schedule H, H1 and X drugs; not yet in force as of September 2026.
2013
Schedule H1 notified.
1945
Drugs and Cosmetics Rules, 1945 made to implement the Act.
Key terms
- Good Storage and Distribution Practices:
- Practices intended to maintain pharmaceutical product quality and identity during storage and distribution.
- Traceability:
- The ability to follow a product through stages of its supply chain using relevant records.
- Central Drugs Standard Control Organisation:
- India's central drug regulatory organisation, which developed the GSDP guidance underlying the proposal.
Good Storage and Distribution Practices: why it matters for exams
Exams: UPSC
Syllabus: Governance: Health regulation and public policy; Society: Public health
Common mistake: Examiners may present the proposed GSDP amendment as an already effective rule; incorporation into the Drugs Rules, 1945 remains a proposal.
Mains practice questions
Question 1(GS-2 | 250 words | 15 marks)
Discuss how incorporating Good Storage and Distribution Practices into the Drugs Rules, 1945 can strengthen the quality and integrity of pharmaceutical products from manufacturer to patient. What challenges may arise in enforcing such guidelines across Central and State drug-control authorities?
Answer outline
- Introduction: Open by noting that quality assurance of medicines does not end at the factory gate, and that the Ministry's proposal seeks to make distribution-stage safeguards legally binding under the Drugs Rules, 1945.
- Body:
- Explain what GSDP covers: procurement, storage, transportation, documentation and record-keeping, and the risks it targets such as deterioration, contamination, mix-ups, falsification and diversion.
- Discuss benefits: legal backing converts guidance into enforceable obligation, improves inspection and enforcement, and fixes accountability across manufacturers, importers, wholesalers, distributors and stockists.
- Discuss the role of CDSCO in framing guidance and of State drug-control authorities in enforcement, highlighting the need for Centre-State coordination and uniform inspection capacity.
- Discuss challenges: fragmented and informal distribution networks, shortage of trained inspectors, documentation burden on small distributors, and cost of cold-chain and storage upgrades.
- Suggest measures such as capacity building, digital tracking of batches, graded compliance support for small entities, and stakeholder consultation during the public comment process.
- Conclusion: Conclude that binding GSDP norms can close a critical gap in drug quality assurance, provided enforcement is backed by adequate human resources, technology and a supportive approach to small supply-chain players.
Question 2(GS-3 | 150 words | 10 marks)
Critically examine why the regulation of pharmaceutical distribution, and not only manufacturing, is essential for public health. How can accountability be enhanced across the supply chain?
Answer outline
- Introduction: Start by stating that a medicine's efficacy can be lost after manufacture if storage and transport are poor, making distribution a public health concern.
- Body:
- Explain the risks at the distribution stage: deterioration due to improper temperature, contamination, mix-ups, falsification and diversion to unauthorised channels.
- Examine how GSDP documentation and record-keeping create traceability, helping regulators trace defective batches and act against spurious drugs.
- Discuss accountability mechanisms: clear responsibilities for each entity, legal liability under the Drugs Rules, and regular inspection by Central and State authorities.
- Note the limitations: compliance costs for small stockists and the need for capacity building and digital systems.
- Conclusion: Conclude that regulating the whole supply chain, backed by traceability and balanced enforcement, is necessary to ensure that quality established at manufacturing reaches the patient intact.
Stuck? Get it in one tap
GSDP means practices for storing and distributing medicines while maintaining their quality. The Ministry of Health and Family Welfare proposes adding these guidelines to the Drugs Rules, 1945. The proposal also encourages records that help track products through the supply chain.
- Governance: Health regulation and public policy
- Society: Public health
Related concepts: Good Storage and Distribution Practices, Traceability, Central Drugs Standard Control Organisation
Practice questions
Pick an answer, then read the explanation.
- Q1Easy
Which organisation developed the guidance underlying the proposed pharmaceutical GSDP framework?
Explanation: The Central Drugs Standard Control Organisation developed the underlying GSDP guidance. The ministry proposed its incorporation into the rules, while Central and State drug-control authorities are involved in oversight and enforcement.
- Q2Hard
Consider the following statements about the proposed pharmaceutical GSDP framework:
- 1. It proposes incorporation into the Drugs Rules, 1945.
- 2. It covers documentation and record-keeping in the distribution chain.
- 3. It is limited to the manufacturing stage and excludes transportation.
Which of the statements given above are correct?
Explanation: Statements 1 and 2 are correct: the proposal concerns the Drugs Rules, 1945 and includes records. Statement 3 is incorrect because the framework also covers transportation and other distribution stages.
- Q3Medium
The proposed GSDP guidelines would be incorporated into the Drugs Rules of which year?
Explanation: The proposal concerns the Drugs Rules, 1945. The other years do not identify the rules targeted by the proposal.
- Q4Medium
What is the primary purpose of the proposed pharmaceutical GSDP framework?
Explanation: The proposed GSDP framework addresses storage, transport and distribution so that product quality is maintained beyond manufacturing. It also promotes records and supports oversight by drug-control authorities rather than restricting checks to factories or transferring inspections to wholesalers.
Frequently asked questions
1. What are the proposed GSDP guidelines for pharmaceuticals?
Good Storage and Distribution Practices are intended to preserve pharmaceutical quality and identity during storage and distribution.
2. Which rules would incorporate the proposed GSDP guidelines?
The proposed amendment concerns the Drugs Rules, 1945.
3. Which organisation developed the guidance underlying the GSDP proposal?
The Central Drugs Standard Control Organisation developed the underlying guidance.
4. How can stakeholders respond to the proposed GSDP amendment?
Stakeholders and members of the public can send objections and suggestions to the Under Secretary (Drugs Regulation), Ministry of Health and Family Welfare.
All sources
Original19 November 2026 · Read story


